Superior Induction of T Cell Responses to Conserved HIV-1 Regions by Electroporated Alphavirus Replicon DNA Compared to That with Conventional Plasmid DNA Vaccine

Regulation of effector and memory T-cell functions by type I interferon

(2011) Jonathan P. Huber et al.   IMMUNOLOGY

Significant Protection against High-Dose Simian Immunodeficiency Virus Challenge Conferred by a New Prime-Boost Vaccine Regimen

(2011) J. B. Schell et al.   JOURNAL OF VIROLOGY

Programming the magnitude and persistence of antibody responses with innate immunity

(2011) Sudhir Pai Kasturi et al.   NATURE

In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers

(2011) Sandhya Vasan et al.   PLoS One

Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines

(2011) Tanja I Näslund et al.   Virology Journal

Protein Kinase R Contributes to Immunity against Specific Viruses by Regulating Interferon mRNA Integrity

(2010) Oliver Schulz et al.   Cell Host & Microbe

Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques

(2010) Maximillian Rosario et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Prime–boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1

(2010) Robert M Paris et al.   Expert Review of Vaccines

Electroporation for DNA immunization: clinical application

(2010) Sylvia van Drunen Littel-van den Hurk et al.   Expert Review of Vaccines

Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device

(2010) K E Broderick et al.   GENE THERAPY

Immunologic Basis of Vaccine Vectors

(2010) Margaret A. Liu   IMMUNITY

Human immunodeficiency virus-1 vaccine design: where do we go now?

(2010) Danushka K Wijesundara et al.   IMMUNOLOGY AND CELL BIOLOGY

Multivalent Smallpox DNA Vaccine Delivered by Intradermal Electroporation Drives Protective Immunity in Nonhuman Primates Against Lethal Monkeypox Challenge

(2010) Lauren A. Hirao et al.   JOURNAL OF INFECTIOUS DISEASES

Semliki Forest Virus-Induced Endoplasmic Reticulum Stress Accelerates Apoptotic Death of Mammalian Cells

(2010) G. Barry et al.   JOURNAL OF VIROLOGY

Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses

(2010) Richard A. Koup et al.   PLoS One

DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer

(2009) Lindsey Low et al.   HUMAN GENE THERAPY

PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response

(2009) G. Barry et al.   JOURNAL OF GENERAL VIROLOGY

Programming for CD8 T Cell Memory Development Requires IL-12 or Type I IFN

(2009) Z. Xiao et al.   JOURNAL OF IMMUNOLOGY

Optimization of Skin Electroporation in Mice to Increase Tolerability of DNA Vaccine Delivery to Patients

(2009) Anna-Karin Roos et al.   MOLECULAR THERAPY

Tolerability of Two Sequential Electroporation Treatments Using MedPulser DNA Delivery System (DDS) in Healthy Adults

(2009) Mark Wallace et al.   MOLECULAR THERAPY

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

(2009) Supachai Rerks-Ngarm et al.   NEW ENGLAND JOURNAL OF MEDICINE

Skin Electroporation: Effects on Transgene Expression, DNA Persistence and Local Tissue Environment

(2009) Anna-Karin Roos et al.   PLoS One

Role of TLR3 in the immunogenicity of replicon plasmid-based vaccines

(2008) S S Diebold et al.   GENE THERAPY

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

(2008) Alexandre Harari et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Broad Immunogenicity of a Multigene, Multiclade HIV‐1 DNA Vaccine Boosted with Heterologous HIV‐1 Recombinant Modified Vaccinia Virus Ankara

(2008) Eric Sandström et al.   JOURNAL OF INFECTIOUS DISEASES

EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone

(2008) Sheena McCormack et al.   VACCINE